Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

46 (2%)

Anticipated shortage:

1 (0%)

Avoided shortage:

19 (1%)

Resolved:

2226 (97%)

2292

Discontinuation Reports

To be discontinued:

4 (3%)

Discontinued:

119 (95%)

Reversed:

2 (2%)

125

453 (19%)

14 (27%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2023-05-30 2023-10-24 193395
SANDOZ SOLIFENACIN 10MG TABLET Resolved 2020-05-11 2020-08-26 114736
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2023-09-19 2023-10-17 204748
SANDOZ SOLIFENACIN 10MG TABLET Resolved 2023-03-13 2023-03-21 186985
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2022-11-16 2022-11-29 175009
SANDOZ SUMATRIPTAN 100MG TABLET Resolved 2017-03-14 2017-05-15 2654
SANDOZ SUNITINIB 12.5MG CAPSULE Resolved 2025-02-03 2025-02-17 249423
SANDOZ SUNITINIB 25MG CAPSULE Resolved 2025-02-03 2025-02-17 249426
SANDOZ SUNITINIB 50MG CAPSULE Resolved 2025-02-03 2025-02-17 249429
SANDOZ TACROLIMUS 0.5MG CAPSULE (IMMEDIATE RELEASE) Resolved 2023-10-23 2023-10-31 207776
SANDOZ TACROLIMUS 1MG CAPSULE (IMMEDIATE RELEASE) Resolved 2025-11-17 2025-12-01 272003
SANDOZ TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Resolved 2021-12-30 2022-01-12 151967
SANDOZ TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Resolved 2017-09-07 2017-11-27 21350
SANDOZ TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Resolved 2023-06-28 2025-05-21 196790
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-08 2023-06-20 192018
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-09-07 2017-10-28 21343
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-10 2023-08-01 197996
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-10 2023-10-31 206701
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-21 2024-11-19 228441
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-21 2024-11-05 228446
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 125